190 related articles for article (PubMed ID: 9000085)
21. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
[TBL] [Abstract][Full Text] [Related]
22. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
[TBL] [Abstract][Full Text] [Related]
23. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
[TBL] [Abstract][Full Text] [Related]
24. CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.
Blaak H; Boers PH; van der Ende ME; Schuitemaker H; Osterhaus AD
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):473-84. PubMed ID: 18327978
[TBL] [Abstract][Full Text] [Related]
25. Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals.
Tsuchie H; Detorio MA; Hossain MM; Tesfamariam N; Trickett A; Lam-Po-Tang PR; Yamada O; Ichimura H; Dwyer JM; Kurimura T
Int J STD AIDS; 1997 May; 8(5):307-10. PubMed ID: 9175652
[TBL] [Abstract][Full Text] [Related]
26. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s).
Hossain MM; Tsuchie H; Detorio MA; Shirono H; Hara C; Nishimoto A; Saji A; Koga J; Takata N; Maniar JK; Saple DG; Taniguchi K; Kageyama S; Ichimura H; Kurimura T
Acta Virol; 1998 Feb; 42(1):47-53. PubMed ID: 9645243
[TBL] [Abstract][Full Text] [Related]
28. Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits.
Tseng CK; Hughes MA; Hsu PL; Mahoney S; Duvic M; Sell S
Am J Pathol; 1991 May; 138(5):1149-64. PubMed ID: 1850960
[TBL] [Abstract][Full Text] [Related]
29. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.
Mackewicz CE; Patterson BK; Lee SA; Levy JA
J Gen Virol; 2000 May; 81(Pt 5):1261-4. PubMed ID: 10769068
[TBL] [Abstract][Full Text] [Related]
30. HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
de Azevedo SSD; Delatorre E; Côrtes FH; Hoagland B; Grinsztejn B; Veloso VG; Souza TML; Morgado MG; Bello G
AIDS; 2019 Mar; 33(3):399-410. PubMed ID: 30531316
[TBL] [Abstract][Full Text] [Related]
31. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
[TBL] [Abstract][Full Text] [Related]
32. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
[TBL] [Abstract][Full Text] [Related]
33. Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.
McBreen S; Imlach S; Shirafuji T; Scott GR; Leen C; Bell JE; Simmonds P
J Virol; 2001 May; 75(9):4091-102. PubMed ID: 11287558
[TBL] [Abstract][Full Text] [Related]
34. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
35. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
36. Characterization of long-term survivors of human immunodeficiency virus type 1 infection.
Cao Y; Qin L; Zhang L; Safrit J; Ho DD
Immunol Lett; 1996 Jun; 51(1-2):7-13. PubMed ID: 8811338
[TBL] [Abstract][Full Text] [Related]
37. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO+CD4+ T lymphocytes.
Holl V; Schmidt S; Aubertin AM; Moog C
Arch Virol; 2007; 152(3):507-18. PubMed ID: 17122895
[TBL] [Abstract][Full Text] [Related]
38. [CD160 characterization and its association with disease progression in patients with chronic HIV-1 infection].
Wang L; Xu X; Feng G; Zhang X; Wang F
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1559-62. PubMed ID: 25146744
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cell-mediated suppression of human immunodeficiency virus replication in older children with acquired immunodeficiency syndrome.
Salimi B; Yogev R; Kabat W; O'Gorman MR; Katz BZ
Pediatr Infect Dis J; 2000 Feb; 19(2):109-13. PubMed ID: 10693995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
